ATARA BIOTHERAPEUTICS, INC. Interest and Other Income
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Interest and Other Income of $380.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2015-11-06
- ATARA BIOTHERAPEUTICS, INC. interest and other income for the quarter ending 2015-09-30 was $380.00K, a 1166.67% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. interest and other income for the quarter ending 2015-06-30 was $163.00K, a 608.70% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. interest and other income for the quarter ending 2015-03-31 was $153.00K, a 2450.00% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. interest and other income for the quarter ending 2014-09-30 was $30.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month |
|---|---|---|---|
| 2015-09-30 | $380.00K 10-Q · filed 2015-11-06 | $543.00K derived: sum of 2 quarters · filed 2015-11-06 | $696.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $163.00K 10-Q · filed 2015-08-07 | $316.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $153.00K 10-Q · filed 2015-05-11 | ||
| 2014-09-30 | $30.00K 10-Q · filed 2015-11-06 | $53.00K derived: sum of 2 quarters · filed 2015-11-06 | $59.00K 10-Q · filed 2015-11-06 |
| 2014-06-30 | $23.00K 10-Q · filed 2015-08-07 | $29.00K 10-Q · filed 2015-08-07 | |
| 2014-03-31 | $6.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |